Drug Delivery Technologies Market Report 2024-2034 - Sustainable and Eco-friendly Innovations in Drug Delivery Technologies [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
World revenue for Drug Delivery Technologies Market is forecast to surpass US$1,700 billion in 2024. The expansion observed in the drug delivery technologies sector can be largely attributed to several key drivers. These include the escalating prevalence of chronic ailments, the burgeoning biologics market, heightened investments in research and development, technological breakthroughs, and the introduction of novel products. Additionally, pharmaceutical and biopharmaceutical enterprises are strategically directing resources towards research and development endeavours aimed at cultivating new molecular entities tailored for diverse therapeutic applications and innovative drug delivery platforms. These companies are committed to substantial investments in research and development endeavours to ensure the delivery of superior-quality and ground-breaking products to the marketplace. Notably, the allocation of funds towards research and development by biopharmaceutical entities has
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Denmark Pharmaceutical Market size is set to grow by USD 852.1 mn from 2024-2028, high investment in pharmaceutical industry to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® [Yahoo! Finance]Yahoo! Finance
- AbbVie Inc. (NYSE: ABBV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $200.00 price target on the stock.MarketBeat
- AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®PR Newswire
- Non Hodgkin Lymphoma (NHL) Global Market Report 2024: Asia-Pacific Set for Swift Growth Amidst Advancements in Immunotherapy and Diagnostic Tools [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 5/17/24 - Form 25-NSE
- 5/8/24 - Form 8-K/A
- 5/7/24 - Form 4
- ABBV's page on the SEC website